Veraxa Biotech, a cancer therapy developer backed by Swiss incubator Xlife Sciences, will go public through a combination with a blank-check entity in a deal that will value the company at as much as ...

Senior Scholar in Residence at the UCLA Law School's Lowell Milken Center For Philanthropy And Nonprofit Law, University of California, Los Angeles The Trump administration is demanding that at ...